News & Analysis as of

Federal Budget Patents

Smart & Biggar

Rx IP Update - March 2019

Smart & Biggar on

Federal Court finds invalidity allegations relating to patent for metformin formulations not justified - On March 8, 2019, Justice Fothergill granted Valeant Canada’s application for an order prohibiting the Minister of...more

Womble Bond Dickinson

Lessons Learned in IP Strategy during the US Government Shutdown

Womble Bond Dickinson on

On January 25, 2019, after 35 days of uncertainty and hundreds of thousands of federal employees missing their second paycheck, the partial government shutdown that went into effect on December 22, 2018 ended. Ramifications...more

McDonnell Boehnen Hulbert & Berghoff LLP

Congress Jumps on Bandwagon to Reduce Biologic Drug Exclusivity Term

Ever since the Biologics Price Competition and Innovation Act (BPCIA) was passed along with the rest of the healthcare law commonly called "Obamacare" in 2010, the Obama Administration has included in every budget a proposal...more

King & Spalding

Washington Insight - July 2014

King & Spalding on

In This Issue: - Progress Toward Comprehensive Patent Reform Stalls - As Attention Turns to a Border Supplemental, a Twelve Bill Omnibus Seems Certain - Highways, Taxes, and Partisanship: The Next Crisis ...more

Womble Bond Dickinson

Hump Day Update

Womble Bond Dickinson on

My head is spinning. Is yours? Happy Hump Day! Last night the Senate Finance Committee had an unusual - and unusual - evening meeting to take up it's version of HB 1030 - Omnibus Tax Changes. Two hours later the bill...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide